Chaudhary, Ninad S.
Donnelly, John P.
Moore, Justin X.
Baddley, John W.
Safford, Monika M.
Wang, Henry E.
Funding for this research was provided by:
National Institute of Nursing Research (R01-NR012726)
National Center for Research Resources (UL1-RR02577)
National Institute of Neurological Disorders and Stroke (U01-NS041588)
Agency for Healthcare Research and Quality (T32-HS013852)
Article History
Received: 7 February 2017
Accepted: 20 June 2017
First Online: 13 July 2017
Ethical approval and consent to participate
: The Institutional Review Board of the University of Alabama at Birmingham approved this study. We obtained informed consent from all participants of the study during baseline visit, and we also obtained consent for subsequent blood samples.
: Not applicable.
: Dr. Safford reports the following potential conflicts of interest: Amgen - salary support to study patterns of statin use in Medicare and other large databases; diaDexus - salary support for a research grant on lipids and CHD outcomes; diaDexus - consulting to help with FDA application; NIH, AHRQ - salary support for research grants. Drs. Wang, Chaudhary, Moore, Donnelly and Baddley do not report any related conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.